Diet-Microbiota Interactions for Irritable Bowel Syndrome
Trial Summary
What is the purpose of this trial?
Most patients suffering from the irritable bowel syndrome (IBS) report that ingestion of certain foods is a major trigger of symptoms, but the reason is unclear. Previous studies have shown that foods containing poorly absorbed carbohydrates (FODMAPs) are fermented by the bacteria in our bowels and these cause symptoms in some but not all patients. Gut bacteria are capable of producing various products, such as neuroimmune mediator histamine, that may be related to IBS symptoms. Our recent data suggest that consumption of FODMAPs promotes production of bacterial histamine. The main objective of this study is to investigate bacterial production of histamine and its relationship to IBS symptoms. The study will involve 6 weeks on a low-FODMAP diet with three three-day interventions consisting of High- or Low-FODMAP drinks along with probiotics or placebo capsules. The patient's bacteria and metabolites will be analyzed at various time points.
Eligibility Criteria
Adults aged 18-75 with IBS who've felt better on a low FODMAP diet or after cutting out high-FODMAP foods, or those whose symptoms improved with antihistamines. They must be able to swallow size 00 capsules and not have other significant GI diseases, systemic diseases like diabetes, active cancer in the last 5 years (except basal cell), be pregnant/breastfeeding, recently in another study, taking antibiotics/probiotics/ACE inhibitors recently, starting new meds within the last month, allergic to ingredients in the study drinks/capsules or have immune-compromising conditions.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- High-FODMAP beverage (DietarySupplement)
- L-Histidine (DietarySupplement)
- Low-FODMAP beverage (DietarySupplement)
- Placebo (Other)
- Probiotics (Probiotics)